Literature DB >> 22592483

Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Bingxue Shang1, Gaochuan Zhang, Yanyan Pan, Quansheng Zhou.   

Abstract

Tumor microenvironment (TME) is important in tumor development and may be a target for anti-cancer therapy. The genesis of TME is a dynamic process that is regulated by intrinsic and extrinsic factors and coordinated by multiple genes, cells, and signal pathways. Cancer anaerobic metabolism and various oncogenes may stimulate the genesis of TME. Tumor cells and cancer stem cells actively participate in the genesis of the cancer stem cell niche and tumor neovascularization, important in the initiation of the TME. Various cancer-associated stromal cells, derived niche factors, and tumor-associated macrophages may function as promoters in the genesis of the TME. Dicer1 gene-deleted stromal cells can induce generation of cancer stem cells and initiate tumorigenesis, suggesting that stromal cells also may promote the genesis of the TME. Therefore, the key features of TME include niche-driving oncogenes, cancer anaerobic metabolism, niche-driving cancer stem cells, neovascularization, tumor-associated inflammatory cells, and cancer-associated stromal cells. These features are potential targets for normalization of the malignant TME and effective anti-cancer therapy.

Entities:  

Year:  2012        PMID: 22592483      PMCID: PMC3460050          DOI: 10.1007/s12307-012-0108-9

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  99 in total

1.  Missense mutations of the BRAF gene in human lung adenocarcinoma.

Authors:  Katsuhiko Naoki; Tzu-Hsiu Chen; William G Richards; David J Sugarbaker; Matthew Meyerson
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 2.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).

Authors:  Alain Charest; Keara Lane; Kevin McMahon; Julie Park; Elizabeth Preisinger; Helen Conroy; David Housman
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

4.  Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.

Authors:  Alexandre Cassago; Amanda P S Ferreira; Igor M Ferreira; Camila Fornezari; Emerson R M Gomes; Kai Su Greene; Humberto M Pereira; Richard C Garratt; Sandra M G Dias; Andre L B Ambrosio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

5.  FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.

Authors:  S Xiao; S R Nalabolu; J C Aster; J Ma; L Abruzzo; E S Jaffe; R Stone; S M Weissman; T J Hudson; J A Fletcher
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

6.  Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

Authors:  Dengli Hong; Rajeev Gupta; Philip Ancliff; Ann Atzberger; John Brown; Shamit Soneji; Joanne Green; Sue Colman; Wanda Piacibello; Veronica Buckle; Shinobu Tsuzuki; Mel Greaves; Tariq Enver
Journal:  Science       Date:  2008-01-18       Impact factor: 47.728

7.  Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma.

Authors:  Roberto Ria; Claudia Piccoli; Teresa Cirulli; Franca Falzetti; Giuseppe Mangialardi; Diego Guidolin; Antonio Tabilio; Nicola Di Renzo; Attilio Guarini; Domenico Ribatti; Franco Dammacco; Angelo Vacca
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

Review 8.  Cancer stem cells, hypoxia and metastasis.

Authors:  Richard P Hill; Delphine T Marie-Egyptienne; David W Hedley
Journal:  Semin Radiat Oncol       Date:  2009-04       Impact factor: 5.934

9.  Prisoner's dilemma in cancer metabolism.

Authors:  Irina Kareva
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression.

Authors:  Michael S Goldberg; Phillip A Sharp
Journal:  J Exp Med       Date:  2012-01-23       Impact factor: 14.307

View more
  5 in total

Review 1.  Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity.

Authors:  Sara Pilotto; Miguel Angel Molina-Vila; Niki Karachaliou; Luisa Carbognin; Santiago Viteri; Maria González-Cao; Emilio Bria; Giampaolo Tortora; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2015-12

2.  Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.

Authors:  Long Jiang; Zerui Zhao; Shanshan Jiang; Yongbin Lin; Han Yang; Zehua Xie; Yaobin Lin; Hao Long
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

3.  -Omics and cancer biomarkers: link to the biological truth or bear the consequences.

Authors:  Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-07-18       Impact factor: 4.254

Review 4.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.

Authors:  Esra A Akbay; Shohei Koyama; Julian Carretero; Abigail Altabef; Jeremy H Tchaicha; Camilla L Christensen; Oliver R Mikse; Andrew D Cherniack; Ellen M Beauchamp; Trevor J Pugh; Matthew D Wilkerson; Peter E Fecci; Mohit Butaney; Jacob B Reibel; Margaret Soucheray; Travis J Cohoon; Pasi A Janne; Matthew Meyerson; D Neil Hayes; Geoffrey I Shapiro; Takeshi Shimamura; Lynette M Sholl; Scott J Rodig; Gordon J Freeman; Peter S Hammerman; Glenn Dranoff; Kwok-Kin Wong
Journal:  Cancer Discov       Date:  2013-09-27       Impact factor: 39.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.